Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses

J Immunol. 1995 Sep 1;155(5):2729-36.

Abstract

Cytotoxic T lymphocyte responses in HIV infection can be impaired through variation in the epitope regions of viral proteins such as a gag. We report here an analysis of variant epitope peptides in three gag epitopes presented by HLA B8. Fifteen variant peptides were examined for their binding to HLA-B8; all but one bound at concentrations comparable to known epitopes. All except two of those that bound could be recognized by CTL from an HLA-B8 positive HIV-1-infected patient and were therefore immunogenic. However, in a hemophiliac patient studied in detail, there was a failure to respond to two immunogenic peptide epitopes representing virus present as provirus in the patient's peripheral blood. In one case, the patient's CTL had previously responded to the peptide; in the other case, there was a good response to a peptide of closely related sequence. Thus there was a selective failure of the CTL response to some proviral epitopes. This impaired reaction to new variants could contribute to the loss of immune control of the infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Viral / immunology
  • Base Sequence
  • CHO Cells
  • Cricetinae
  • Cytotoxicity Tests, Immunologic
  • Epitopes / genetics
  • Epitopes / immunology
  • Female
  • Gene Products, gag / immunology
  • Gene Products, gag / metabolism
  • Genetic Variation
  • HIV Antigens / genetics*
  • HIV Antigens / immunology
  • HIV Antigens / metabolism*
  • HIV Infections / immunology
  • HLA-B8 Antigen / metabolism*
  • Humans
  • Lymphocyte Activation / immunology
  • Molecular Sequence Data
  • Protein Binding / immunology
  • Proviruses / immunology
  • T-Lymphocytes, Cytotoxic / immunology*

Substances

  • Antigens, Viral
  • Epitopes
  • Gene Products, gag
  • HIV Antigens
  • HLA-B8 Antigen